Skip to main content

Advertisement

Table 1 Baseline patient, angiographic and procedural characteristics according to diabetes status

From: Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes

Variable No diabetes (n = 834) Diabetes (n = 371) P value
Age (years) 60 (51–68) 60 (53–68) 0.811
Male 675 (80.9) 280 (75.5) 0.031
Current smoker 467 (56.0) 183 (49.3) 0.032
Hypertension 495 (59.4) 242 (65.2) 0.053
Dyslipidemia 480 (57.6) 230 (62.0) 0.148
Previous myocardial infarction 39 (4.7) 26 (7.0) 0.098
Previous PCI 42 (5.0) 28 (7.5) 0.085
Previous stroke 74 (8.9) 44 (11.9) 0.107
Peripheral vascular disease 20 (2.4) 16 (4.3) 0.072
CKD in treatment 16 (1.9) 10 (2.7) 0.392
OSAHS 14 (1.7) 2 (0.5) 0.171
Heart rate (beats/min) 76 (68–85) 78 (70–85) 0.101
Systolic blood pressure (mmHg) 120 (108–130) 120 (110–130) 0.236
Laboratory data
 Peak troponin (μg/L) 68 (28–102) 73 (28–102) 0.808
 Peak CK (U/L) 2101 (1124–3404) 1977 (987–3347) 0.204
 Peak CK-MB (U/L) 227 (120–305) 173 (85–299) < 0.001
Time from symptom onset to PCI (h) 5.0 (3.0–7.0) 5.0 (3.5–8.0) 0.009
Killip class III/IV 74 (8.9) 46 (12.4) 0.059
Radial artery access 295 (35.4) 151 (40.7) 0.077
No. narrowed coronary arteries 0.778
 Two 580 (69.5) 255 (68.7)  
 Three 254 (30.5) 116 (31.3)  
Culprit vessel 0.832
 Left anterior descending 325 (39.0) 138 (37.2)  
 Left circumflex 112 (13.4) 50 (13.5)  
 Right 397 (47.6) 183 (49.3)  
Non-culprit artery
 Left anterior descending 370 (44.4) 178 (48.0) 0.245
 Left circumflex 453 (54.3) 197 (53.1) 0.696
 Right 266 (31.9) 111 (29.9) 0.495
Thrombus aspiration 582 (69.8) 234 (63.1) 0.021
No-reflow phenomenon 80 (9.6) 37 (10.0) 0.837
Intra-aortic balloon pump use 83 (10.0) 36 (9.7) 0.894
Glycoprotein IIb/IIIa inhibitor use 224 (26.9) 91 (24.5) 0.395
Temporary pacemaker 20 (2.4) 15 (4.0) 0.116
Defibrillator 43 (5.2) 18 (4.9) 0.824
Drug-eluting stent use 809 (97.0) 360 (97.0) 0.975
Type of stent 0.276
 1st drug-eluting stent 634 (76.0) 265 (71.4)  
 2nd drug-eluting stent 175 (21.0) 95 (25.6)  
 Bare-mental stent 2 (0.2) 2 (0.5)  
 PTCA 23 (2.8) 9 (2.4)  
Stent number 1 (1–2) 1 (1–2) 0.137
Total stent length (mm) 33 (24–48) 30 (24–42) 0.080
Minimum stent diameter (mm) 3.00 (2.50–3.50) 3.00 (2.50–3.50) 0.338
Medications at discharge
 Aspirin 833 (99.9) 371 (100.0) 1.000
 P2Y12 receptor inhibitor 834 (100.0) 371 (100.0) 1.000
 ACEI/ARB 617 (74.0) 269 (72.5) 0.592
 β-blockers 693 (83.1) 331 (89.2) 0.006
 Statins 826 (99.0) 370 (99.7) 0.289
Acute kidney injurya 177 (21.3) 74 (21.0) 0.602
  1. ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, CKD chronic kidney disease, CK-MB creatine kinase myocardial band, OSAHS obstructive sleep apnea-hypopnea syndrome, PCI percutaneous coronary intervention, PTCA percutaneous transluminal coronary angioplasty
  2. aData of acute kidney injury was obtained from 1200 (99.6%) patients